Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02147860 · ClinicalTrials.gov registry record · NA
Full Day and Night Closed-Loop With DiAs Platform
A NA study, sponsored by University of Virginia.
- Completed
- Registry status
- NA
- Development phase
- 44
- Enrollment target
NCT02147860: Completed NA study, sponsored by University of Virginia.
NCT02147860 is a NA study that has completed, run by University of Virginia. The registered enrollment target is 44 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02147860, a NA study, has completed, sponsored by University of Virginia.
- COMPLETED
- Registry status
- NA
- Development phase
- 44 participants
- Enrollment target
Study Summary
The overall aim of this proposed research is to determine the safety, feasibility and efficacy of the Diabetes Assistant (DiAs) controller in day and night closed-loop control in children and adolescents with type 1 diabetes over multiple days in a diabetes camp setting. This will be addressed in two parts: 1) An in residence, outpatient study to determine safety and feasibility of the DiAs during 72 continuous hours of day and night glucose control; and 2) Camp studies planned for the summer of 2014 with randomization to either full closed-loop or sensor-augmented pump therapy over the duration of 6-7 day diabetes camps.
Primary Outcome
Determine the efficacy of glucose control, as determined by the percentage of sensor glucose readings in the target range
Interventions
- OTHER Sensor Augmented Pump Therapy
- DEVICE Diabetes Assistant (DiAs) with USS Virginia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2014-05 |
| Est. Completion | 2015-01 |
| Phase | NA |
What the finished NCT02147860 record still lists
NCT02147860 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 44 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 2 interventions - of which Sensor Augmented Pump Therapy is the first listed.
NCT02147860 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02147860 about?
NCT02147860 is a clinical study titled "Full Day and Night Closed-Loop With DiAs Platform". The overall aim of this proposed research is to determine the safety, feasibility and efficacy of the Diabetes Assistant (DiAs) controller in day and night closed-loop control in children and adolescents with type 1 diabetes over multiple days in a diabetes camp setting. This will be addressed in tw...
What is the current status of trial NCT02147860?
This trial is currently completed. It is a NA study. The enrollment target is 44 participants. The study started on 2014-05. Estimated completion is 2015-01.
What interventions are being tested in trial NCT02147860?
The interventions under investigation include: Sensor Augmented Pump Therapy (OTHER), Diabetes Assistant (DiAs) with USS Virginia (DEVICE).
Who is sponsoring clinical trial NCT02147860?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02147860's enrollment target sits among peer trials
44 1423rd of 2000 higher than 566 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02323945 · 44 participants · NA
Effects of Breathing Mild Bouts of Low Oxygen on Limb Mobility After Spinal Injury
- NCT03093909 · 44 participants · Phase 1
Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases
- NCT03104491 · 44 participants · Phase 1
Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia
- NCT03781765 · 44 participants · Phase 4
Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia